The huge North American retail warehouse chain will market the RESPeRATE in its catalogue and online.
InterCure Ltd. a> (TASE:INCR) has concluded an agreement with North American warehouse chain Costco, which will significantly expand sales of its device RESPeRATE for lowering blood pressure. The device will appear in Costco's mail order calatlogue from February 2010, which is circulated to 23 million members.
InterCure also says that the RESPeRATE will be the first medical device ever marketed on-line by Costco.com.
Intercure's CEO Erez Gavish said, "The agreement with Costco is an additional important and central step in applying the company's strategy of consolidating and deepening retail sales channels. The fact that the giant Costco in the US decided to expand sales of the RESPeRATE is the best proof of the quality of the device, the level of interest in it, and the growing awareness and satisfaction of consumers using the new generation of the device. The new agreement will enable InterCure to jump a level in penetrating the US market with the RESPeRATE and in concoldating its position in the strongest and most stable retail market in the world."
Published by Globes [online], Israel business news - www.globes-online.com - on December 1, 2009
© Copyright of Globes Publisher Itonut (1983) Ltd. 2009